Yumei Liu – Trademark Portfolio
Entity Type: 01
Yumei Liu owns a portfolio of 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as MEKTIX, QIVARA, BISEAYON, ELYSTARA, and SENGLVRI. Of these, 9 are registered. The portfolio spans 6 Nice Classification classes, led by Class 3 (Cosmetics & Cleaning) and Class 25 (Clothing). Headquartered in Shenzhen, Guangdong.
Bao'an District
Room 110, No. 101, Xixingye Road
Shenzhen, Guangdong 518000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Yumei Liu's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Precious metals and their alloys; jewellery, precious stones; horological instruments
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does Yumei Liu have?
Yumei Liu has 11 U.S. trademarks filed with the USPTO. Of these, 9 registered, 2 abandoned.
What trademark classes does Yumei Liu file in?
Yumei Liu files trademarks across 6 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 25 (Clothing), Class 14 (Jewelry), Class 11 (Environmental Control), Class 10 (Medical Apparatus). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are Yumei Liu's most well-known trademarks?
Yumei Liu's registered trademark portfolio includes well-known marks such as MEKTIX, QIVARA, BISEAYON, ELYSTARA, and SENGLVRI. These are among 9 currently registered trademarks in the portfolio.
What is Yumei Liu's trademark registration success rate?
Yumei Liu has a 82% trademark registration rate, with 9 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.